The company's Seg-Flow® Automated On-line Sampling System offers multiple bioprocess monitoring and control solutions, utilizing patented Segmented On-line Sampling™ technology. The system allows rapid and accurate sampling for 8 vessels or process streams and sample delivery to 4 analyzers and/or fraction collectors. Additionally, it seamlessly integrates existing off-line and at-line analytics into a multi-functional on-line PAT tool through the Seg-Flow system's communication interface and FlowWeb™ control software.
With a vision to continually innovate, Flownamics® presents an intriguing opportunity for investors seeking to support cutting-edge technologies in the biotechnology sector. Despite the absence of recent investment data, the company's commitment to developing new technologies and serving the global biotechnology industry positions it as a potential prospect for future investment considerations.